Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Evans Daron | CFO | 32 | $693.6K | $0 | 2026-10-21 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | 8 | $19.6K | $0 | 2026-09-02 |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | 32 | $247.5K | $0 | 2026-07-02 |
| Elam Nevan C | Chief Executive Officer | 22 | $94.3K | $0 | 2026-07-02 |
| Hogenhuis Wladimir | Director | 16 | $261.3K | $0 | 2025-12-16 |
| FAUCHET PHILIPPE | Director | 9 | $0 | $0 | 2025-11-19 |
| Harris Erik | Director | 3 | $0 | $0 | 2025-11-19 |
| Kim Young-Jin | Director | 11 | $9.37M | $0 | 2025-11-19 |
| KREHER NERISSA | Director | 10 | $10.0K | $0 | 2025-11-19 |
| Labrucherie Gil M | Director | 11 | $400.0K | $0 | 2025-11-19 |
| HANDOK, INC. | Director, 10% Owner | 74 | $30.53M | $0 | 2022-07-22 |
| Vendola Keith A. | Chief Financial Officer | 1 | $0 | $0 | 2019-07-31 |
| Mantripragada Sankaram | Chief Scientific Officer | 1 | $0 | $0 | 2019-07-31 |
| Genexine Inc. | 10% Owner | 3 | $10.00M | $0 | 2019-07-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | G Gift | 2026-10-21 | 2026-10-23 | 4,000 | — | $0 | 11,000 | SEC↗ |
| Evans Daron | CFO | G Gift | 2026-10-21 | 2026-10-23 | 4,000 | — | $0 | 11,000 | SEC↗ |
| Evans Daron | CFO | G Gift | 2026-10-21 | 2026-10-23 | 16,000 | — | $0 | 395,400 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,267 | $4.50 | $10.2K | 69,275 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | F Tax w/h | 2026-09-02 | 2026-09-03 | 2,267 | $4.50 | $10.2K | 69,275 | SEC↗ |
| Evans Daron | CFO | F Tax w/h | 2026-07-02 | 2026-07-07 | 3,062 | $4.99 | $15.3K | 411,400 | SEC↗ |
| Elam Nevan C | CEO | F Tax w/h | 2026-07-02 | 2026-07-07 | 8,004 | $4.99 | $39.9K | 605,497 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | F Tax w/h | 2026-07-02 | 2026-07-07 | 3,062 | $4.99 | $15.3K | 293,851 | SEC↗ |
| Evans Daron | CFO | P Buy | 2026-03-30 | 2026-03-31 | 10,000 | $2.85 | $28.5K | 414,462 | SEC↗ |
| Elam Nevan C | CEO | F Tax w/h | 2026-03-02 | 2026-03-04 | 27,618 | $2.99 | $82.6K | 613,501 | SEC↗ |
| Evans Daron | CFO | F Tax w/h | 2026-03-02 | 2026-03-04 | 11,438 | $2.99 | $34.2K | 404,462 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | F Tax w/h | 2026-03-02 | 2026-03-04 | 11,439 | $2.99 | $34.2K | 296,913 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2025-12-16 | 2025-12-17 | 28,000 | $1.70 | $47.6K | 308,352 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2025-12-16 | 2025-12-17 | 5,650 | $1.69 | $9.5K | 119,675 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | P Buy | 2025-12-15 | 2025-12-15 | 12,000 | $1.62 | $19.4K | 71,442 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | P Buy | 2025-12-15 | 2025-12-15 | 100 | $1.60 | $160 | 71,542 | SEC↗ |
| Elam Nevan C | CEO | P Buy | 2025-12-15 | 2025-12-15 | 32,000 | $1.59 | $50.9K | 641,119 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-12-15 | 2025-12-15 | 2,500 | $1.79 | $4.5K | 7,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-12-15 | 2025-12-15 | 2,500 | $1.79 | $4.5K | 7,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-12-15 | 2025-12-15 | 40,000 | $1.77 | $70.8K | 415,900 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-12-09 | 2024-12-10 | 10,549 | $5.04 | $53.2K | 131,900 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Kim Young-Jin | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Harris Erik | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Evans Daron | CFO | A Award deriv | 2025-11-19 | 2025-11-21 | 63,000 | — | $0 | 63,000 | SEC↗ |
| Elam Nevan C | CEO | A Award deriv | 2025-11-19 | 2025-11-21 | 186,000 | — | $0 | 186,000 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A Award deriv | 2025-11-19 | 2025-11-21 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 55,500 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 55,500 | SEC↗ |
| Kim Young-Jin | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 170,950 | SEC↗ |
| Harris Erik | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 114,025 | SEC↗ |
| KREHER NERISSA | Director | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 58,576 | SEC↗ |
| Evans Daron | CFO | A Award | 2025-11-19 | 2025-11-21 | 107,000 | — | $0 | 375,900 | SEC↗ |
| Elam Nevan C | CEO | A Award | 2025-11-19 | 2025-11-21 | 317,000 | — | $0 | 609,119 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A Award | 2025-11-19 | 2025-11-21 | 32,000 | — | $0 | 59,442 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award | 2025-11-19 | 2025-11-21 | 123,000 | — | $0 | 280,352 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A Award deriv | 2025-08-18 | 2025-08-27 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Karnawat Sunil Ratilal | Chief Commercial Officer | A Award | 2025-08-18 | 2025-08-27 | 25,000 | — | $0 | 27,442 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2025-06-25 | 2025-06-26 | 2,500 | $4.38 | $10.9K | 15,500 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-06-24 | 2025-06-24 | 5,000 | $4.05 | $20.3K | 268,900 | SEC↗ |
| KREHER NERISSA | Director | P Buy | 2025-06-13 | 2025-06-23 | 3,076 | $3.25 | $10.0K | 37,576 | SEC↗ |
| Kim Young-Jin | Director | P Buy | 2025-06-13 | 2025-06-23 | 1,230,769 | $3.25 | $4.00M | 8,423,386 | SEC↗ |
| Elam Nevan C | CEO | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award deriv | 2025-06-10 | 2025-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Evans Daron | CFO | A Award deriv | 2025-06-10 | 2025-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kim Young-Jin | Director | A Award deriv | 2025-06-10 | 2025-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2025-06-10 | 2025-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2025-06-10 | 2025-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2025-06-10 | 2025-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Elam Nevan C | CEO | A Award | 2025-06-10 | 2025-06-12 | 68,000 | — | $0 | 292,119 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award | 2025-06-10 | 2025-06-12 | 26,000 | — | $0 | 157,352 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award | 2025-06-10 | 2025-06-12 | 9,000 | — | $0 | 34,500 | SEC↗ |
| Evans Daron | CFO | A Award | 2025-06-10 | 2025-06-12 | 26,000 | — | $0 | 263,900 | SEC↗ |
| Kim Young-Jin | Director | A Award | 2025-06-10 | 2025-06-12 | 9,000 | — | $0 | 149,950 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award | 2025-06-10 | 2025-06-13 | 9,000 | — | $0 | 93,025 | SEC↗ |
| Labrucherie Gil M | Director | A Award | 2025-06-10 | 2025-06-13 | 9,000 | — | $0 | 34,500 | SEC↗ |
| KREHER NERISSA | Director | A Award | 2025-06-10 | 2025-06-13 | 9,000 | — | $0 | 34,500 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2025-03-31 | 2025-04-01 | 6,758 | $2.92 | $19.7K | 84,025 | SEC↗ |
| Elam Nevan C | CEO | P Buy | 2025-03-27 | 2025-03-31 | 12,302 | $2.85 | $35.1K | 224,119 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-03-26 | 2025-03-28 | 10,000 | $2.88 | $28.8K | 23,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2025-03-26 | 2025-03-28 | 10,000 | $2.89 | $28.9K | 237,900 | SEC↗ |
| Harris Erik | Director | A Award deriv | 2025-03-25 | 2025-03-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2025-02-18 | 2025-02-20 | 10,000 | $4.70 | $47.0K | 77,267 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2025-02-16 | 2025-02-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Elam Nevan C | CEO | A Award deriv | 2025-02-16 | 2025-02-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award deriv | 2025-02-16 | 2025-02-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Kim Young-Jin | Director | A Award deriv | 2025-02-16 | 2025-02-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2025-02-16 | 2025-02-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Evans Daron | CFO | A Award deriv | 2025-02-16 | 2025-02-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2025-02-16 | 2025-02-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2025-02-16 | 2025-02-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award | 2025-02-16 | 2025-02-19 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Elam Nevan C | CEO | A Award | 2025-02-16 | 2025-02-19 | 204,000 | — | $0 | 211,817 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award | 2025-02-16 | 2025-02-19 | 77,000 | — | $0 | 131,352 | SEC↗ |
| Kim Young-Jin | Director | A Award | 2025-02-16 | 2025-02-19 | 25,500 | — | $0 | 140,950 | SEC↗ |
| KREHER NERISSA | Director | A Award | 2025-02-16 | 2025-02-19 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Evans Daron | CFO | A Award | 2025-02-16 | 2025-02-19 | 77,000 | — | $0 | 227,900 | SEC↗ |
| Labrucherie Gil M | Director | A Award | 2025-02-16 | 2025-02-20 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award | 2025-02-16 | 2025-02-20 | 25,500 | — | $0 | 67,267 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-12-18 | 2024-12-18 | 10,000 | $4.29 | $42.9K | 150,900 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-12-12 | 2024-12-12 | 9,000 | $4.60 | $41.4K | 140,900 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2024-09-24 | 2024-09-24 | 4,259 | $4.70 | $20.0K | 41,767 | SEC↗ |
| Evans Daron | CFO | A Award deriv | 2024-09-23 | 2024-09-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kim Young-Jin | Director | P Buy | 2024-06-25 | 2025-02-19 | 1,250,000 | $4.00 | $5.00M | 7,192,617 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2024-06-25 | 2024-06-27 | 4,815 | $4.15 | $20.0K | 37,508 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-06-14 | 2024-06-14 | 40,000 | $4.04 | $161.6K | 40,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-06-14 | 2024-06-14 | 300 | $3.97 | $1.2K | 1,376 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-06-14 | 2024-06-14 | 4,000 | $3.91 | $15.6K | 54,052 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-06-14 | 2024-06-14 | 300 | $3.96 | $1.2K | 54,352 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-06-14 | 2024-06-14 | 3,000 | $3.91 | $11.7K | 13,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-05-29 | 2024-05-31 | 451 | $3.50 | $1.6K | 121,351 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-05-24 | 2024-05-28 | 2,942 | $3.23 | $9.5K | 13,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-05-23 | 2024-05-28 | 58 | $2.85 | $165 | 10,058 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-05-23 | 2024-05-28 | 1,500 | $2.72 | $4.1K | 44,052 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-05-23 | 2024-05-28 | 6,000 | $2.68 | $16.1K | 50,052 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-03-28 | 2024-03-29 | 500 | $2.55 | $1.3K | 1,076 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-03-15 | 2024-03-19 | 20,000 | $1.69 | $33.8K | 20,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-03-14 | 2024-03-18 | 10,000 | $1.88 | $18.8K | 10,000 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-03-08 | 2024-03-08 | 50,000 | $1.93 | $96.5K | 120,900 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-03-07 | 2024-03-11 | 500 | $1.85 | $925 | 500 | SEC↗ |
| Kim Young-Jin | Director | P Buy | 2024-03-07 | 2024-03-14 | 36,503 | $1.91 | $69.7K | 115,450 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-03-07 | 2024-03-18 | 500 | $1.85 | $925 | 576 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-02-26 | 2024-02-27 | 2,000 | $1.70 | $3.4K | 42,552 | SEC↗ |
| Elam Nevan C | CEO | P Buy | 2024-02-26 | 2024-02-28 | 5,000 | $1.68 | $8.4K | 7,817 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-02-23 | 2024-02-27 | 6,000 | $1.69 | $10.1K | 40,552 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-02-16 | 2024-02-20 | 41,900 | $1.30 | $54.5K | 70,900 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-02-16 | 2024-02-20 | 4,500 | $1.37 | $6.2K | 4,500 | SEC↗ |
| Evans Daron | CFO | P Buy | 2024-02-16 | 2024-02-20 | 4,500 | $1.37 | $6.2K | 4,500 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2024-02-16 | 2024-02-21 | 7,000 | $1.31 | $9.2K | 34,552 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Elam Nevan C | CEO | A Award deriv | 2024-01-23 | 2024-01-25 | 340,000 | — | $0 | 340,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | A Award deriv | 2024-01-23 | 2024-01-25 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Evans Daron | CFO | A Award deriv | 2024-01-23 | 2024-01-25 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | P Buy | 2023-07-03 | 2023-07-06 | 5,000 | $1.90 | $9.5K | 27,552 | SEC↗ |
| Kim Young-Jin | Director | P Buy | 2022-07-22 | 2024-03-14 | 78,947 | $3.80 | $300.0K | 78,947 | SEC↗ |
| HANDOK, INC. | Director, 10% Owner | P Buy | 2022-07-22 | 2024-03-19 | 3,157,895 | $3.80 | $12.00M | 5,942,617 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | A Award deriv | 2022-06-23 | 2022-06-27 | 2,600,000 | — | $0 | 2,600,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | A Award deriv | 2022-06-23 | 2022-06-27 | 700,000 | — | $0 | 700,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Kim Young-Jin | Director | A Award deriv | 2022-06-23 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | P Buy | 2022-05-19 | 2022-05-19 | 300 | $2.95 | $885 | 22,552 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | P Buy | 2022-05-18 | 2022-05-19 | 200 | $2.86 | $572 | 22,252 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | P Buy | 2022-05-17 | 2022-05-19 | 1,000 | $3.41 | $3.4K | 22,052 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2022-05-04 | 2022-05-06 | 25,000 | $3.80 | $95.0K | 32,693 | SEC↗ |
| Labrucherie Gil M | Director | P Buy | 2022-05-04 | 2022-05-06 | 52,631 | $3.80 | $200.0K | 52,631 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | P Buy | 2022-05-04 | 2022-05-06 | 21,052 | $3.80 | $80.0K | 21,052 | SEC↗ |
| Labrucherie Gil M | Director | P Buy | 2022-05-04 | 2022-05-09 | 52,631 | $3.80 | $200.0K | 53,572 | SEC↗ |
| HANDOK, INC. | Director, 10% Owner | P Buy | 2021-10-15 | 2024-03-19 | 769,231 | $6.50 | $5.00M | 2,784,722 | SEC↗ |
| Hogenhuis Wladimir | Director | P Buy | 2021-10-15 | 2022-05-06 | 7,693 | $6.50 | $50.0K | 7,693 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-07-14 | 70,000 | — | $0 | 0 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | A Award deriv | 2021-06-14 | 2021-07-14 | 375,000 | — | $0 | 675,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-07-14 | 100,000 | — | $0 | 575,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-07-14 | 34,800 | — | $0 | 0 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | D To issuer deriv | 2021-06-14 | 2021-07-14 | 20,000 | — | $0 | 0 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | D To issuer deriv | 2021-06-14 | 2021-07-14 | 9,000 | — | $0 | 0 | SEC↗ |
| ROBERTS BRIAN KENNETH | Sr VP, Clinic Development | A Award deriv | 2021-06-14 | 2021-07-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Labrucherie Gil M | Director | A Award deriv | 2021-06-14 | 2021-07-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KREHER NERISSA | Director | A Award deriv | 2021-06-14 | 2021-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FAUCHET PHILIPPE | Director | A Award deriv | 2021-06-14 | 2021-07-14 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Hogenhuis Wladimir | Director | A Award deriv | 2021-06-14 | 2021-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-08-31 | 100,000 | — | $0 | 575,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | A Award deriv | 2021-06-14 | 2021-08-31 | 375,000 | — | $0 | 675,000 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-08-31 | 70,000 | — | $0 | 0 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | D To issuer deriv | 2021-06-14 | 2021-08-31 | 34,800 | — | $0 | 0 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-13 | 2020-10-14 | 2,500 | $23.35 | $58.4K | 2,015,491 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-12 | 2020-10-14 | 125,000 | $0.46 | $57.5K | 100,649,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-07 | 2020-10-08 | 125,000 | $0.41 | $51.3K | 100,524,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-06 | 2020-10-07 | 125,000 | $0.42 | $52.5K | 100,399,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-05 | 2020-10-07 | 125,000 | $0.46 | $57.5K | 100,274,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-02 | 2020-10-05 | 125,000 | $0.45 | $56.3K | 100,149,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-10-01 | 2020-10-02 | 125,000 | $0.44 | $55.0K | 100,024,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-30 | 2020-10-02 | 125,000 | $0.44 | $55.0K | 99,899,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-29 | 2020-09-30 | 125,000 | $0.45 | $56.3K | 99,774,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-28 | 2020-09-30 | 125,000 | $0.44 | $55.0K | 99,649,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-25 | 2020-09-28 | 125,000 | $0.45 | $56.3K | 99,524,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-24 | 2020-09-25 | 125,000 | $0.44 | $55.0K | 99,399,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-23 | 2020-09-25 | 125,000 | $0.46 | $57.5K | 99,274,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-22 | 2020-09-23 | 125,000 | $0.46 | $57.5K | 99,149,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-21 | 2020-09-23 | 125,000 | $0.46 | $57.5K | 99,024,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-18 | 2020-09-21 | 125,000 | $0.46 | $57.5K | 98,899,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-17 | 2020-09-18 | 125,000 | $0.46 | $57.5K | 98,774,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-16 | 2020-09-18 | 125,000 | $0.46 | $57.5K | 98,649,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-15 | 2020-09-16 | 125,000 | $0.45 | $56.3K | 98,524,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-14 | 2020-09-16 | 125,000 | $0.46 | $57.5K | 98,399,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-11 | 2020-09-15 | 125,000 | $0.49 | $61.3K | 98,274,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-10 | 2020-09-14 | 125,000 | $0.49 | $61.3K | 98,149,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-09 | 2020-09-10 | 125,000 | $0.49 | $61.3K | 98,024,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-08 | 2020-09-10 | 125,000 | $0.45 | $56.3K | 97,899,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-04 | 2020-09-08 | 125,000 | $0.48 | $60.0K | 97,774,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-03 | 2020-09-04 | 125,000 | $0.49 | $61.3K | 97,649,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-02 | 2020-09-04 | 125,000 | $0.58 | $72.5K | 97,524,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-09-01 | 2020-09-02 | 125,000 | $0.55 | $68.8K | 97,399,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-31 | 2020-09-02 | 125,000 | $0.48 | $60.0K | 97,274,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-28 | 2020-09-01 | 125,000 | $0.49 | $61.3K | 97,149,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-27 | 2020-08-28 | 125,000 | $0.47 | $58.8K | 97,024,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-26 | 2020-08-28 | 125,000 | $0.47 | $58.8K | 96,899,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-25 | 2020-08-26 | 125,000 | $0.50 | $62.5K | 96,774,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-24 | 2020-08-26 | 125,000 | $0.49 | $61.3K | 96,649,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-21 | 2020-08-25 | 125,000 | $0.47 | $58.8K | 96,524,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-20 | 2020-08-21 | 125,000 | $0.46 | $57.5K | 96,399,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-19 | 2020-08-21 | 125,000 | $0.45 | $56.3K | 96,274,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-18 | 2020-08-19 | 125,000 | $0.49 | $61.3K | 96,149,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-17 | 2020-08-19 | 125,000 | $0.48 | $60.0K | 96,024,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-14 | 2020-08-18 | 125,000 | $0.41 | $51.3K | 95,899,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-13 | 2020-08-14 | 184,941 | $0.35 | $64.7K | 95,774,528 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-12 | 2020-08-14 | 125,000 | $0.40 | $50.0K | 95,589,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-11 | 2020-08-12 | 125,000 | $0.43 | $53.8K | 95,464,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 125,000 | $0.34 | $42.5K | 95,339,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-07 | 2020-08-11 | 125,000 | $0.35 | $43.8K | 95,214,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-06 | 2020-08-07 | 125,000 | $0.36 | $45.0K | 95,089,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-05 | 2020-08-07 | 125,000 | $0.35 | $43.8K | 94,964,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-04 | 2020-08-05 | 125,000 | $0.34 | $42.5K | 94,839,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-08-03 | 2020-08-04 | 125,000 | $0.34 | $42.5K | 94,714,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-31 | 2020-08-03 | 250,000 | $0.31 | $77.5K | 94,589,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-30 | 2020-08-03 | 125,000 | $0.32 | $40.0K | 94,339,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-29 | 2020-07-30 | 125,000 | $0.34 | $42.5K | 94,214,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-28 | 2020-07-30 | 125,000 | $0.32 | $40.0K | 94,089,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-27 | 2020-07-28 | 125,000 | $0.34 | $42.5K | 93,964,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-24 | 2020-07-28 | 125,000 | $0.31 | $38.8K | 93,839,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-23 | 2020-07-24 | 187,000 | $0.30 | $56.1K | 93,714,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-22 | 2020-07-24 | 250,000 | $0.28 | $70.0K | 93,527,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-21 | 2020-07-22 | 250,000 | $0.25 | $62.5K | 93,277,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-20 | 2020-07-21 | 250,000 | $0.26 | $65.0K | 93,027,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-17 | 2020-07-21 | 250,000 | $0.21 | $52.5K | 92,777,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-16 | 2020-07-17 | 250,000 | $0.19 | $47.5K | 92,527,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-15 | 2020-07-16 | 250,000 | $0.16 | $40.0K | 92,277,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-14 | 2020-07-15 | 84,000 | $0.16 | $13.4K | 92,027,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-13 | 2020-07-14 | 100,000 | $0.15 | $15.0K | 91,943,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-10 | 2020-07-14 | 18,550 | $0.13 | $2.4K | 91,843,587 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-09 | 2020-07-14 | 133,804 | $0.13 | $17.4K | 91,825,037 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-08 | 2020-07-14 | 45,200 | $0.12 | $5.4K | 91,691,233 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-07 | 2020-07-14 | 45,100 | $0.11 | $5.0K | 91,646,033 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2020-07-06 | 2020-07-14 | 300,000 | $0.10 | $30.0K | 91,600,933 | SEC↗ |
| Elam Nevan C | Chief Executive Officer | A Award deriv | 2019-07-31 | 2019-09-16 | 15,000,000 | — | $0 | 15,000,000 | SEC↗ |
| Mantripragada Sankaram | Chief Scientific Officer | A Award deriv | 2019-07-31 | 2019-09-16 | 3,500,000 | — | $0 | 3,500,000 | SEC↗ |
| Vendola Keith A. | Chief Financial Officer | A Award deriv | 2019-07-31 | 2019-09-16 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| Genexine Inc. | 10% Owner | P Buy | 2019-07-23 | 2021-07-28 | 34,482,758 | $0.29 | $10.00M | 91,300,933 | SEC↗ |
| HANDOK, INC. | 10% Owner | P Buy | 2019-07-23 | 2020-03-31 | 34,482,758 | $0.29 | $10.00M | 91,300,933 | SEC↗ |
| Genexine Inc. | 10% Owner | C Conversion deriv | 2019-04-26 | 2021-07-28 | 1,250,000 | $10.00 | $12.50M | 0 | SEC↗ |
| Genexine Inc. | 10% Owner | C Conversion | 2019-04-26 | 2021-07-28 | 56,818,175 | — | $0 | 56,818,175 | SEC↗ |
| HANDOK, INC. | 10% Owner | C Conversion deriv | 2019-04-26 | 2020-03-31 | 1,250,000 | $10.00 | $12.50M | 0 | SEC↗ |
| HANDOK, INC. | 10% Owner | C Conversion | 2019-04-26 | 2020-03-31 | 56,818,175 | — | $0 | 56,818,175 | SEC↗ |